Prot# CC-5013-MM-014: A Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Efficacy of Single Agent CC-5013 in Subjects with Relapsed and Refractory Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date9/2/03 → 12/30/05

Funding

  • Celgene Corporation (CC-5013-MM-014)